Intersect ENT shares dip despite street-beating Q4, 2018 earnings

Shares in Intersect ENT (NSDQ:XENT) have fallen slightly today despite the medical device maker released fourth quarter and full year 2018 earnings that met consensus expectations from analysts on Wall Street. The Menlo Park, Calif.-based company posted losses of $5 million, or 16¢ per share, on sales of approximately $32.8 million for the three months ended December 31, seeing losses grow 59.6% while sales grew 11% compared with the same period during the previous year. Read the whole story on our sister site Drug Delivery Business News The post Intersect ENT shares dip despite street-beating Q4, 2018 earnings appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Business/Financial News MassDevice Earnings Roundup Wall Street Beat intersectent Source Type: news